Dr. Larry Einhorn is known for revolutionizing testicular cancer treatment. His research resulted in a groundbreaking treatment that moved the survival rate from 5% to 95%. We are grateful to have him as a member of our Board of Directors and pillar of the Conquer Cancer community.
Dr. Chi Viet planned to be a dentist, encountering patients with oral cancers who suffered poor outcomes. This changed the trajectory of her career, eventually leading her to a fellowship in head and neck surgical oncology and microvascular reconstruction. https://bit.ly/4taQMCC
It's time for our Annual Impact Report! We are excited to share the incredible advancements in oncology you made possible last year through your generous support.
Your gifts go a long way in protecting progress in oncology for people with cancer everywhere. Read the report: https://bit.ly/3Q2mHWV
Conquer Cancer’s EveryGrant announces Quality Improvement grants, funded by Pfizer, to leverage technology to improve biomarker-driven testing and treatment. Congratulations to the recipients! Read the full release: https://bit.ly/4v1FmSK
#EveryGrant #ConquerCancer #ResearchConquersCancer
It takes a special crowd of people dedicated to changing the cancer landscape to run Conquer Cancer. These are just a few of the determined people who help make sure your gifts advance progress in oncology. 🧡
#ConquerCancer #ResearchConquersCancer #CancerResearch
Your support in 2025 went a long way in protecting progress in oncology for people with cancer everywhere. We can't wait to see what you'll help accomplish in 2026! Read the full report: https://bit.ly/47RMjw3
#ImpactReport #ResearchConquersCancer #ConquerCancer
Colorectal cancer is no longer just "an older person’s disease." It is now a leading cause of cancer-related death for men and women under 50. The good news? Conquer Cancer has directed $6.6M to 78 scientists working to help people with this disease. Read our latest blog: https://bit.ly/4v11hd2
Did you catch the March issue of the @ascocancer.bsky.social Connection magazine? Conquer Cancer is prominently featured along with the impact our donors make when they invest in the work of oncology clinicians and researchers. Read the details in the full digital edition: https://bit.ly/4lWvmGu
FINAL REMINDER! The deadline for the LBCA Early Investigator ILC Research Grant is March 30! Don't miss your chance to secure funding for your #ILC research. Apply today! https://bit.ly/4uojzED
#CancerResearch #EveryGrant
Did you know that Conquer Cancer has funded over $3.6 million in triple negative breast cancer research? Thanks to individual donors and corporate partners 28 research projects have gotten off the ground and explored new possibilities for people with #TNBC.
#TNBCawarenessMonth
Recognizing the need to improve the experience and quality of care for patients with bladder cancer, Pfizer Global Medical Grants, working with Conquer Cancer’s EveryGrant, funded 6 new quality improvement grants totaling about $1.5M. Learn more: https://bit.ly/4b1PzWa
Today is #RareDiseaseDay. While cancer as a whole is prevalent, more than 198 forms are classified as rare. At Conquer Cancer, we fund researchers who are dedicated to closing this gap and accelerating breakthroughs for every type of cancer, including the rare. https://bit.ly/4rLAZJC
For centuries, the story of cancer was one of limited options, but today, we are rewriting that narrative. Read our overview of what cancer is, why it’s so hard to treat, and how research transforms our understanding of it. https://bit.ly/4qWeMra
#CancerResearch #ResearchConquersCancer
We are pleased to announce the recipients of 2026 Genitourinary Cancers Symposium Merit Awards selected for presentation at the @ascocancer.bsky.social Genitourinary Cancers Symposium, February 26-28. Congrats!
See the full list of recipients here: https://bit.ly/46L2fzq
#GU26
New Funding opportunity! Applications are OPEN for the @lobularbca.bsky.social Early Investigator Invasive Lobular Carcinoma (ILC) Research Grant. Support for early-stage investigators to build a career in #ILC research. Apply by March 30, 2026! https://bit.ly/4tA0AX7
#ResearchConquersCancer
The story of cancer was once one of limited options, but today, we are rewriting that narrative. Read our overview of why cancer so hard to treat, and how research is transforming our understanding of it, accelerating treatment progress and improving patients’ lives. https://bit.ly/3O2gklL
Ever wonder how a lifesaving idea gets funded? Here’s a peek behind the curtain. Learn more at: https://bit.ly/4tpNhIH
For @chemtaimungo.bsky.social conquering cancer means ensuring that people everywhere have access to care that removes fear. On #WorldCancerDay, we recognize the importance of funding researchers focused on cancer care for people everywhere. Dr. Mungo's Spotlight: https://bit.ly/3ZjDGpf
Dr. Chemtai Mungo discusses how early-career research funding not only supports the next generation of scientists but also leads to improved cancer care across the globe. Read the blog: https://bit.ly/45ID8No #WorldCancerDay
Remember when the music community came together to get #LouderThanCancer? With #WorldCancerDay this week, we're remembering the impact made as these artists shared what it means to be Louder than Cancer. The playlist is still available! https://bit.ly/4teXpUN
Conquer Cancer is pleased to recognize the 29 recipients of its 2026 IDEA Awards.
This provides funding for early-career oncology professionals in LMICs along with mentorship and networking support. See the announcement: https://bit.ly/4kbsTHa
Despite advancements in recent decades, cervical cancer still ranks the fourth most common cancer in women across the globe. Fortunately, the best and brightest researchers are working worldwide on ways to help create better treatments and prevention for women everywhere. #CervicalCancerAwareness
According to the CDC, 90% of #cervicalcancer cases are caused by HPV. Lillian Kreppel, of HPV Cancers Alliance, is no stranger to the impact of the virus.
This #CervicalCancerAwareness Month, listen to our Your Stories podcast with Lillian and her mission for HPV awareness: https://bit.ly/49PXBB7
After decades of investment in cancer research, why isn't there universal cure yet?
The reality is cancer isn’t a single disease with a single solution—it is a collection of unique diseases, each with its own challenges. Read more in our blog post: https://bit.ly/49thXjn
We are pleased to announce the recipients of 2026 Gastrointestinal Cancers Symposium Merit Awards selected for presentation at the @ascocancer.bsky.social Gastrointestinal Cancers Symposium, January 8–10. Congrats! See the full list of recipients: https://bit.ly/49hHWdq #ASCOGI26
This month, Conquer Cancer hosted our Scientific and Career Development Retreat at ASCO headquarters. We were thrilled to hear from expert panels, speakers, poster presenters, and more. Thanks to all who joined us!
Showcase your expertise to leaders in the international GU scientific community & generate fresh collaborations by sharing your research at #GU26—The Place to Be Heard.
Submit an abstract to our 2026 ASCO Genitourinary Symposium by the Oct 21 deadline: brnw.ch/21wVrHY
Nearly half of all soft tissue sarcoma patients experience a recurrence, but Dr. Abdulazeez Salawu's research offers hope. He found that ctDNA can signal recurrence weeks before it shows up on scans. Read more: www.conquer.org/impact/accel...
#RareCancer #ResearchConquersCancer
Congratulations to the recipients of the 2025 Quality Care Symposium Merit Awards. These 42 oncology professionals are recognized for their respective field and research advancements within the cancer care community. See the list: www.conquer.org/news/conquer... @ascocancer.bsky.social #ASCOQLTY25
For Dr. Michael Kinnaman, developing meaningful relationships with his patients is critical. The fact that his patients are children, makes his work all the more fulfilling. Learn more about how he helps kids facing cancer. www.conquer.org/cancer-resea...
